Latest Regulatory Approval News

High Peak Royalties reported steady royalty income for Q1 2025, completed a significant geothermal asset sale to Northstar Energy, and achieved a debt-free balance sheet following full repayment of its Macquarie facility.

Eastern Metals reports a quiet March quarter with no exploration activity, a CEO resignation, and plans for significant capital raises alongside a proposed acquisition of Raptor Resources.

Conrad Asia Energy has secured a pivotal Gas Sales Agreement with Indonesia’s state utility PLN, linking Mako gas prices to the Indonesian Crude Price and advancing its farmout strategy while increasing its stake in the Duyung PSC to 91.5%.

Mineral Commodities Ltd faces a buyer default on its Skaland sale while advancing negotiations to fully acquire the Munglinup Graphite Project, amidst operational and financial challenges.

Toubani Resources has cemented a fiscal agreement with the State of Mali under the 2023 mining code, advancing its Kobada Gold Project toward a final investment decision. A strategic A$29 million placement led by A2MP Investments further strengthens the company’s development pathway.

New Murchison Gold Limited reports breakthrough ultra-high grade gold intercepts at Crown Prince alongside a robust feasibility study and strong funding position, setting the stage for mid-2025 mining commencement.

Emperor Energy has submitted a key Environmental Plan to NOPSEMA, marking a major step towards drilling the Judith-2 appraisal well in mid-2026 amid tightening east coast gas supply. The company also appointed industry veteran Douglas Jendry as Chairman to steer its next phase.

Terragen Holdings has launched its new probiotic products for ruminants, initiated multiple key trials including methane mitigation and crop yield studies, and secured a US patent allowance, positioning itself for global market expansion.

Zenith Minerals reported a pivotal quarter advancing exploration at its Dulcie Far North and Red Mountain gold projects, while agreeing to divest its Turkish Kavaklitepe interest, sharpening its focus on domestic assets.

EVE Health Group has executed a binding agreement to acquire Australian biotech Nextract, targeting rapid-onset treatments in the $16 billion global erectile dysfunction and dysmenorrhea markets. The acquisition, supported by a $1.5 million capital raise and share consolidation, marks a strategic shift into regulated pharmaceutical channels.

Avenira Limited is advancing its Wonarah Phosphate Project with site mobilisation planned for mid-2025, backed by a $7.567 million capital injection from major shareholder Sichuan Hebang Technology. Operational milestones and regulatory approvals are progressing, positioning the company for first ore shipment in Q4.

Highfield Resources has made significant progress on its strategic transaction with Yankuang Energy and Beijing Energy, securing key regulatory approvals and restructuring its financing amid disciplined cost management.